Skip to main content
Independent journalism needs independent support.Subscribe to TJM
Advertise
Boston & beyond
Talking Joints MemoIndependent reporting on cannabis, psychedelics & culture
National News

Congressional Shake-Up Bolsters Prospects For Federal Marijuana Reforms

"Some two thirds of Americans support ending marijuana prohibition, and policies that punish responsible consumers and patients are increasingly out of step with voters across the political spectrum."

Following Democratic lawmakers’ substantial gains on election night, NORML anticipates that members of the 120th Congress will be more willing to advance legislation addressing federal marijuana policy.

This includes legislative proposals to remove cannabis from the Controlled Substances Act, improve commercial cannabis businesses’ access to financial services, facilitate veterans’ access to medical cannabis, and repeal federally imposed housing and employment discrimination upon cannabis consumers.

“Some two thirds of Americans support ending marijuana prohibition, and policies that punish responsible consumers and patients are increasingly out of step with voters across the political spectrum. Unfortunately, Republican leadership chose to ignore public sentiment and let popular cannabis policy legislation languish this session,” said NORML’s Political Director Morgan Fox. “Hopefully Democrats will not make the same mistake, and will provide the necessary leadership and bipartisanship to pass substantive, sensible reforms in the 120th Congress.”

Historically, cannabis-related federal legislation has fared better under Democratic control. For example, in 2020 and 2022, members of the Democratic-led House passed legislation, the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, removing marijuana from the federal Controlled Substances Act. On seven separate occasions, House members also passed legislation, the Secure and Fair Enforcement (SAFE) Banking Act, explicitly permitting banks and other financial institutions to partner with state-licensed cannabis operators.

Earlier this year, US Attorney General Todd Blanche issued an executive order reclassifying state-regulated medical cannabis products to Schedule III of the Controlled Substances Act. However, the Administration has yet to provide clear guidance on the issue. Administrative efforts to reclassify all botanical cannabis to Schedule III remain ongoing.

“With the future of rescheduling still uncertain and its practical effects not yet fully defined, it is vital that federal lawmakers take on these issues,” said Fox. “The fate of federal marijuana policy should not be left in the hands of bureaucrats and judges. It is Congress who initially prohibited marijuana and it is Congress who ultimately needs to abolish this failed federal policy, specifically by descheduling cannabis and by passing other reforms that provide real-world relief and protections for millions of responsible consumers.”

He added, “Lawmakers should begin preparing now to prioritize this issue as early as possible in the next session. NORML looks forward to working with members of both parties to make meaningful legislative progress in the 120th Congress. The American people deserve federal cannabis policies grounded in science, public health, personal freedom, and justice.

This brief was reprinted from NORML. Additional information on Election Day results is available from NORML’s Election Central.

NORML
About the author

Since its founding in 1970, NORML has provided a voice in the public policy debate for those Americans who oppose marijuana prohibition and favor an end to the practice of arresting marijuana consumers. A nonprofit public-interest advocacy group, NORML represents the interests of the tens of millions of Americans who use marijuana responsibly.